Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors
Clinical trial NCT06849921 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06849921
- Sponsor
- Ruijin Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-07
- Primary completion
- 2030-12-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.